查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813533

GLP-1 市場分析及至2034年的預測：按類型、產品、服務、技術、應用、最終用戶、部署、設備和流程

GLP 1 Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Deployment, Device, Process
出版日期: | 出版商: Global Insight Services | 英文 312 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

GLP-1 市場預計將從2024年的937億美元擴大到2034年的2,218億美元，年複合成長率約為 9%。 GLP-1 市場包括Glucagon-Like Peptide-1受體促效劑，這類藥物主要用於治療第2 型糖尿病和肥胖症。這些藥物能夠刺激胰島素分泌、抑制食慾並延緩排放。糖尿病和肥胖率的上升刺激了需求，創新藥物則著重於緩釋性和聯合治療。 GLP-1 市場的發展受到醫療保健意識增強和有利的償付政策的推動。

受糖尿病和肥胖症盛行率上升的推動，GLP-1 市場正經歷強勁成長。受糖尿病和肥胖症盛行率上升的推動，GLP-1 市場正經歷強勁成長。Semaglutide和Liraglutide因其療效和患者依從性而推動市場發展。這些藥物因其有效控制血糖值的能力而廣受歡迎。表現第二好的子領域是聯合治療，該療法因能夠透過靶向多種途徑來提高治療效果而發展動力強勁。除了藥理學上的進步之外，給藥系統領域也出現了重大創新。注射筆和自動注射器處於領先地位，提供方便和準確的給藥。同時，由於患者對非侵入性選擇的偏好，口服 GLP-1 製劑正成為一個有前景的子領域。增加致力於提高生物有效性和延長作用時間的研發投資預計將擴大治療領域並抓住新的成長機會。

市場區隔
類型 胜肽類GLP-1促效劑、非胜肽類GLP-1促效劑
產品 注射型 GLP-1促效劑、口服 GLP-1促效劑
營業內容 臨床試驗、監理諮詢、藥物安全檢測
技術 重組DNA技術、化學合成
用途 2型糖尿病、肥胖管理、心血管應用
最終用戶 醫院、診所、科研院所、製藥公司
部署 內部、外包
裝置 胰島素筆、注射器和自動注射器
流程 藥物發現、開發和製造

市場概述

GLP-1 市場的特點是，不同的參與者透過策略定價和創新產品發布爭奪主導地位。由於新療法和改進配方的推出，GLP-1 市場的市場佔有率波動劇烈。定價策略非常重要，公司透過競爭性定價來擴大市場佔有率。新產品的頻繁推出反映了該行業致力於滿足未滿足的醫療需求和擴大患者治療選擇的承諾。 GLP-1 市場的競爭非常激烈，大型製藥公司在研發方面投入大量資金以保持競爭力。監管影響也發揮關鍵作用，嚴格的指導方針決定了產品開發和上市策略。市場經歷戰略夥伴關係和聯盟的激增，目的是加速創新和擴大市場准入。北美和歐洲的法規結構尤其具有影響力，它們規定了合規標準並影響市場動態。新興企業將新觀點和新技術帶到了前沿，使競爭格局更加複雜。

主要趨勢和促進因素

受全球肥胖症和糖尿病盛行率上升的推動，GLP-1 市場正經歷強勁成長。 GLP-1 受體促效劑在體重管理和血糖控制方面的有效性日益受到認可，這推動了市場需求的成長。製藥公司正大力投資研發，以推出創新且更有效的製劑。一個關鍵趨勢是開發便捷的口服 GLP-1 受體促效劑作為注射劑的替代品。此外，各大製藥公司也建立策略夥伴關係和聯盟，以加強通路並擴大市場覆蓋範圍。個人化醫療和以患者為中心的方法正變得越來越普遍，治療方案可根據患者的個人情況量身定做。由於 GLP-1 療法有可能降低與糖尿病併發症相關的長期醫療成本，因此對降低醫療成本的日益關注正推動其應用。新興市場蘊藏著巨大的商機，這些市場醫療基礎設施的改善和可支配收入的增加使人們獲得先進治療方法的機會日益增多。在技術創新和策略市場定位的推動下，GLP-1 市場預計將大幅擴張。

限制與挑戰：

GLP-1 市場面臨一些重大的限制和挑戰。主要阻礙因素之一是 GLP-1 療法價格高昂，這限制了許多患者的使用並限制了市場滲透。此外，嚴格的監管要求和冗長的核准流程構成了重大障礙，減緩了新產品和創新的推出。另一個值得注意的挑戰是醫療專業人員和患者對 GLP-1 療法的認知和理解有限。這種低認知可能導致這些治療方法未被充分利用。此外，市場還面臨來自替代療法的競爭，例如生活方式介入和其他藥物療法，這些方案可能會嚇跑潛在患者，使他們不願接受 GLP-1 治療。最後，管理與 GLP-1 療法相關的副作用的複雜性也帶來了挑戰。醫療保健提供者必須仔細監測和管理這些副作用，這會使治療方法複雜化並抑制患者的依從性。

主要企業

Ascendis Pharma、Hanmi Pharmaceuticals、Oramed Pharmaceuticals、Adocia、Chiasma、Amphastar Pharmaceuticals、Intarcia Therapeutics、Carmot Therapeutics、Diasome Pharmaceuticals、TheracosBio、Viking Therapeutics、Eiger BioPharmaceuticals、Protagonist Therapeutics、Scohia Pharma、Zydus Cadila

目錄

第1章 GLP-1市場概述

  • 調查目的
  • GLP-1市場定義與範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章 執行摘要

第3章 重要考察

第4章 GLP-1 市場展望

  • GLP-1市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • ANSOFF矩陣

第5章 GLP-1市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章 GLP-1市場規模

  • GLP-1 市場規模：依金額
  • GLP-1 市場規模：依數量

第7章 GLP-1 市場規模（依類型）

  • 市場概況
  • 胜肽類GLP-1促效劑
  • 非胜肽類GLP-1促效劑
  • 其他

第8章 GLP-1 產品市場

  • 市場概況
  • 注射型GLP-1促效劑
  • 口服GLP-1促效劑
  • 其他

第9章 GLP-1 市場（依服務）

  • 市場概況
  • 臨床試驗
  • 藥事諮詢
  • 藥物安全檢測
  • 其他

第10章 GLP-1 市場：依技術

  • 市場概況
  • 重組DNA技術
  • 化學合成
  • 其他

第11章 GLP-1 市場：依應用

  • 市場概況
  • 2型糖尿病
  • 肥胖管理
  • 心血管應用
  • 其他

第12章 GLP-1市場（依最終用戶）

  • 市場概況
  • 醫院
  • 診所
  • 研究所
  • 製藥公司
  • 其他

第13章 GLP-1 市場：依發展

  • 市場概況
  • 內部
  • 外包
  • 其他

第14章 GLP-1 市場（依設備）

  • 市場概況
  • 胰島素筆
  • 注射器
  • 自動注射器
  • 其他

第15章 GLP-1 市場（依過程）

  • 市場概況
  • 藥物研發
  • 藥物開發
  • 製造業
  • 其他

第16章 GLP-1 市場（依地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第17章 競爭格局

  • 概述
  • 市場佔有率分析
  • 主要企業定位
  • 競爭領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第18章 公司簡介

  • Ascendis Pharma
  • Hanmi Pharmaceutical
  • Oramed Pharmaceuticals
  • Adocia
  • Chiasma
  • Amphastar Pharmaceuticals
  • Intarcia Therapeutics
  • Carmot Therapeutics
  • Diasome Pharmaceuticals
  • TheracosBio
  • Viking Therapeutics
  • Eiger BioPharmaceuticals
  • Protagonist Therapeutics
  • Scohia Pharma
  • Zydus Cadila
簡介目錄
Product Code: GIS33906

GLP 1 Market is anticipated to expand from $93.7 billion in 2024 to $221.8 billion by 2034, growing at a CAGR of approximately 9%. The GLP-1 Market encompasses glucagon-like peptide-1 receptor agonists, a class of medications primarily used for managing type 2 diabetes and obesity. These agents enhance insulin secretion, suppress appetite, and slow gastric emptying. Rising diabetes prevalence and obesity rates fuel demand, with innovations focusing on extended-release formulations and combination therapies. The market is propelled by increasing healthcare awareness and favorable reimbursement policies.

The GLP-1 market is experiencing robust growth, propelled by the rising prevalence of diabetes and obesity. Within this market, the drug segment is the top performer, with semaglutide and liraglutide leading due to their efficacy and patient compliance. These drugs are favored for their ability to manage blood glucose levels effectively. The second highest performing sub-segment is the combination therapies, which are gaining momentum as they offer enhanced therapeutic benefits by targeting multiple pathways. In addition to pharmacological advancements, the delivery systems segment is witnessing significant innovation. Injectable pens and auto-injectors are at the forefront, offering convenience and precision in dosage administration. Meanwhile, oral GLP-1 formulations are emerging as a promising sub-segment, driven by patient preference for non-invasive options. Research and development investments are intensifying, focusing on improving bioavailability and extending the duration of action, thereby broadening the therapeutic landscape and unlocking new opportunities for growth.

Market Segmentation
TypePeptide-Based GLP-1 Agonists, Non-Peptide GLP-1 Agonists
ProductInjectable GLP-1 Agonists, Oral GLP-1 Agonists
ServicesClinical Trials, Regulatory Consulting, Pharmacovigilance
TechnologyRecombinant DNA Technology, Chemical Synthesis
ApplicationType 2 Diabetes, Obesity Management, Cardiovascular Applications
End UserHospitals, Clinics, Research Institutes, Pharmaceutical Companies
DeploymentIn-House, Outsourced
DeviceInsulin Pens, Syringes, Auto-Injectors
ProcessDrug Discovery, Drug Development, Manufacturing

Market Snapshot:

The GLP-1 market is characterized by a diverse array of market players, each vying for dominance through strategic pricing and innovative product launches. The landscape is defined by dynamic shifts in market share, influenced by the introduction of novel therapeutics and enhanced formulations. Pricing strategies are pivotal, with companies leveraging competitive pricing to capture greater market presence. New product launches are frequent, reflecting the industry's commitment to addressing unmet medical needs and expanding therapeutic options for patients. Competition within the GLP-1 market is intense, with leading pharmaceutical companies investing heavily in research and development to maintain their competitive edge. Regulatory influences play a crucial role, with stringent guidelines shaping product development and market entry strategies. The market is witnessing a surge in strategic partnerships and collaborations, aimed at accelerating innovation and expanding market reach. Regulatory frameworks in North America and Europe are particularly impactful, dictating compliance standards and influencing market dynamics. The competitive landscape is further complicated by emerging players, who bring fresh perspectives and novel technologies to the fore.

Geographical Overview:

The GLP-1 market is witnessing substantial growth across various regions, each showcasing unique dynamics. North America remains a dominant force, propelled by increasing prevalence of diabetes and obesity. The region benefits from robust healthcare infrastructure and heightened awareness of GLP-1 therapies. Europe follows closely, where strong healthcare systems and rising awareness of diabetes management are driving market expansion. In the Asia Pacific, the market is expanding swiftly due to a rising diabetic population and increased healthcare spending. Emerging economies like China and India are pivotal growth pockets, with significant investments in healthcare infrastructure. Latin America and the Middle East & Africa are also emerging markets. In Latin America, growing healthcare investments and improving access to diabetes treatments are notable. The Middle East & Africa are recognizing the importance of addressing lifestyle diseases, thus fostering demand for GLP-1 therapies. These regions offer lucrative opportunities for market players aiming to expand their global footprint.

Key Trends and Drivers:

The GLP-1 market is experiencing robust growth, propelled by rising obesity and diabetes prevalence worldwide. Increasing awareness of GLP-1 receptor agonists' efficacy in weight management and glycemic control is driving demand. Pharmaceutical companies are investing heavily in research and development to introduce innovative and more effective formulations. Key trends include the development of oral GLP-1 receptor agonists, offering a convenient alternative to injectable forms. The market is also witnessing strategic partnerships and collaborations to enhance distribution networks and expand market reach. Personalized medicine and patient-centric approaches are gaining traction, aligning treatments with individual patient profiles. The increasing focus on healthcare cost reduction is encouraging the adoption of GLP-1 therapies, given their potential to reduce long-term healthcare expenses associated with diabetes complications. Opportunities abound in emerging markets, where healthcare infrastructure improvements and rising disposable incomes are facilitating greater access to advanced therapies. The GLP-1 market is poised for significant expansion, driven by innovation and strategic market positioning.

Restraints and Challenges:

The GLP-1 market is encountering several significant restraints and challenges. One primary restraint is the high cost of GLP-1 therapies, which limits access for many patients and restricts market penetration. Additionally, stringent regulatory requirements and lengthy approval processes pose significant hurdles, delaying the introduction of new products and innovations. There is also a notable challenge in the form of limited awareness and understanding of GLP-1 therapies among healthcare professionals and patients. This lack of awareness can lead to underutilization of these therapies. Furthermore, the market faces competition from alternative treatment options, such as lifestyle interventions and other pharmacological therapies, which can divert potential patients away from GLP-1 treatments. Lastly, the complexity of managing side effects associated with GLP-1 therapies presents a challenge. Healthcare providers need to carefully monitor and manage these side effects, which can complicate treatment regimens and deter patient adherence.

Key Players:

Ascendis Pharma, Hanmi Pharmaceutical, Oramed Pharmaceuticals, Adocia, Chiasma, Amphastar Pharmaceuticals, Intarcia Therapeutics, Carmot Therapeutics, Diasome Pharmaceuticals, TheracosBio, Viking Therapeutics, Eiger BioPharmaceuticals, Protagonist Therapeutics, Scohia Pharma, Zydus Cadila

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: GLP 1 Market Overview

  • 1.1 Objectives of the Study
  • 1.2 GLP 1 Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Deployment
  • 2.10 Key Highlights of the Market, by Device
  • 2.11 Key Highlights of the Market, by Process
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Deployment
  • 3.9 Market Attractiveness Analysis, by Device
  • 3.10 Market Attractiveness Analysis, by Process
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: GLP 1 Market Outlook

  • 4.1 GLP 1 Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: GLP 1 Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: GLP 1 Market Size

  • 6.1 GLP 1 Market Size, by Value
  • 6.2 GLP 1 Market Size, by Volume

7: GLP 1 Market, by Type

  • 7.1 Market Overview
  • 7.2 Peptide-Based GLP-1 Agonists
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Non-Peptide GLP-1 Agonists
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: GLP 1 Market, by Product

  • 8.1 Market Overview
  • 8.2 Injectable GLP-1 Agonists
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Oral GLP-1 Agonists
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Others
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region

9: GLP 1 Market, by Services

  • 9.1 Market Overview
  • 9.2 Clinical Trials
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Regulatory Consulting
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Pharmacovigilance
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: GLP 1 Market, by Technology

  • 10.1 Market Overview
  • 10.2 Recombinant DNA Technology
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Chemical Synthesis
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Others
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region

11: GLP 1 Market, by Application

  • 11.1 Market Overview
  • 11.2 Type 2 Diabetes
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Obesity Management
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Cardiovascular Applications
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: GLP 1 Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Clinics
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Pharmaceutical Companies
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: GLP 1 Market, by Deployment

  • 13.1 Market Overview
  • 13.2 In-House
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Outsourced
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: GLP 1 Market, by Device

  • 14.1 Market Overview
  • 14.2 Insulin Pens
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Syringes
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Auto-Injectors
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: GLP 1 Market, by Process

  • 15.1 Market Overview
  • 15.2 Drug Discovery
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Drug Development
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Manufacturing
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: GLP 1 Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by End User
    • 16.2.8 North America Market Size and Forecast, by Deployment
    • 16.2.9 North America Market Size and Forecast, by Device
    • 16.2.10 North America Market Size and Forecast, by Process
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by End User
      • 16.2.9.7 United States Market Size and Forecast, by Deployment
      • 16.2.9.8 United States Market Size and Forecast, by Device
      • 16.2.9.9 United States Market Size and Forecast, by Process
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by End User
      • 16.2.10.7 Canada Market Size and Forecast, by Deployment
      • 16.2.10.8 Canada Market Size and Forecast, by Device
      • 16.2.10.9 Canada Market Size and Forecast, by Process
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by End User
    • 16.3.8 Europe Market Size and Forecast, by Deployment
    • 16.3.9 Europe Market Size and Forecast, by Device
    • 16.3.10 Europe Market Size and Forecast, by Process
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Deployment
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by End User
      • 16.3.10.7 Germany Market Size and Forecast, by Deployment
      • 16.3.10.8 Germany Market Size and Forecast, by Device
      • 16.3.10.9 Germany Market Size and Forecast, by Process
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by End User
      • 16.3.11.7 France Market Size and Forecast, by Deployment
      • 16.3.11.8 France Market Size and Forecast, by Device
      • 16.3.11.9 France Market Size and Forecast, by Process
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by End User
      • 16.3.12.7 Spain Market Size and Forecast, by Deployment
      • 16.3.12.8 Spain Market Size and Forecast, by Device
      • 16.3.12.9 Spain Market Size and Forecast, by Process
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by End User
      • 16.3.13.7 Italy Market Size and Forecast, by Deployment
      • 16.3.13.8 Italy Market Size and Forecast, by Device
      • 16.3.13.9 Italy Market Size and Forecast, by Process
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by End User
      • 16.3.14.7 Netherlands Market Size and Forecast, by Deployment
      • 16.3.14.8 Netherlands Market Size and Forecast, by Device
      • 16.3.14.9 Netherlands Market Size and Forecast, by Process
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by End User
      • 16.3.15.7 Sweden Market Size and Forecast, by Deployment
      • 16.3.15.8 Sweden Market Size and Forecast, by Device
      • 16.3.15.9 Sweden Market Size and Forecast, by Process
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by End User
      • 16.3.16.7 Switzerland Market Size and Forecast, by Deployment
      • 16.3.16.8 Switzerland Market Size and Forecast, by Device
      • 16.3.16.9 Switzerland Market Size and Forecast, by Process
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by End User
      • 16.3.17.7 Denmark Market Size and Forecast, by Deployment
      • 16.3.17.8 Denmark Market Size and Forecast, by Device
      • 16.3.17.9 Denmark Market Size and Forecast, by Process
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by End User
      • 16.3.18.7 Finland Market Size and Forecast, by Deployment
      • 16.3.18.8 Finland Market Size and Forecast, by Device
      • 16.3.18.9 Finland Market Size and Forecast, by Process
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by End User
      • 16.3.19.7 Russia Market Size and Forecast, by Deployment
      • 16.3.19.8 Russia Market Size and Forecast, by Device
      • 16.3.19.9 Russia Market Size and Forecast, by Process
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Deployment
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Deployment
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by End User
      • 16.4.9.7 China Market Size and Forecast, by Deployment
      • 16.4.9.8 China Market Size and Forecast, by Device
      • 16.4.9.9 China Market Size and Forecast, by Process
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by End User
      • 16.4.10.7 India Market Size and Forecast, by Deployment
      • 16.4.10.8 India Market Size and Forecast, by Device
      • 16.4.10.9 India Market Size and Forecast, by Process
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by End User
      • 16.4.11.7 Japan Market Size and Forecast, by Deployment
      • 16.4.11.8 Japan Market Size and Forecast, by Device
      • 16.4.11.9 Japan Market Size and Forecast, by Process
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by End User
      • 16.4.12.7 South Korea Market Size and Forecast, by Deployment
      • 16.4.12.8 South Korea Market Size and Forecast, by Device
      • 16.4.12.9 South Korea Market Size and Forecast, by Process
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by End User
      • 16.4.13.7 Australia Market Size and Forecast, by Deployment
      • 16.4.13.8 Australia Market Size and Forecast, by Device
      • 16.4.13.9 Australia Market Size and Forecast, by Process
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by End User
      • 16.4.14.7 Singapore Market Size and Forecast, by Deployment
      • 16.4.14.8 Singapore Market Size and Forecast, by Device
      • 16.4.14.9 Singapore Market Size and Forecast, by Process
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by End User
      • 16.4.15.7 Indonesia Market Size and Forecast, by Deployment
      • 16.4.15.8 Indonesia Market Size and Forecast, by Device
      • 16.4.15.9 Indonesia Market Size and Forecast, by Process
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by End User
      • 16.4.16.7 Taiwan Market Size and Forecast, by Deployment
      • 16.4.16.8 Taiwan Market Size and Forecast, by Device
      • 16.4.16.9 Taiwan Market Size and Forecast, by Process
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by End User
      • 16.4.17.7 Malaysia Market Size and Forecast, by Deployment
      • 16.4.17.8 Malaysia Market Size and Forecast, by Device
      • 16.4.17.9 Malaysia Market Size and Forecast, by Process
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by End User
    • 16.5.8 Latin America Market Size and Forecast, by Deployment
    • 16.5.9 Latin America Market Size and Forecast, by Device
    • 16.5.10 Latin America Market Size and Forecast, by Process
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by End User
      • 16.5.9.7 Brazil Market Size and Forecast, by Deployment
      • 16.5.9.8 Brazil Market Size and Forecast, by Device
      • 16.5.9.9 Brazil Market Size and Forecast, by Process
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by End User
      • 16.5.10.7 Mexico Market Size and Forecast, by Deployment
      • 16.5.10.8 Mexico Market Size and Forecast, by Device
      • 16.5.10.9 Mexico Market Size and Forecast, by Process
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by End User
      • 16.5.11.7 Argentina Market Size and Forecast, by Deployment
      • 16.5.11.8 Argentina Market Size and Forecast, by Device
      • 16.5.11.9 Argentina Market Size and Forecast, by Process
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Deployment
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Deployment
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Deployment
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by End User
      • 16.6.10.7 UAE Market Size and Forecast, by Deployment
      • 16.6.10.8 UAE Market Size and Forecast, by Device
      • 16.6.10.9 UAE Market Size and Forecast, by Process
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by End User
      • 16.6.11.7 South Africa Market Size and Forecast, by Deployment
      • 16.6.11.8 South Africa Market Size and Forecast, by Device
      • 16.6.11.9 South Africa Market Size and Forecast, by Process
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Deployment
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Ascendis Pharma
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Hanmi Pharmaceutical
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Oramed Pharmaceuticals
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Adocia
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Chiasma
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Amphastar Pharmaceuticals
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Intarcia Therapeutics
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Carmot Therapeutics
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Diasome Pharmaceuticals
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 TheracosBio
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Viking Therapeutics
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Eiger BioPharmaceuticals
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Protagonist Therapeutics
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Scohia Pharma
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Zydus Cadila
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis